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Assessment of Relationships Between
Site-Specific Variables
P.P. Hujoel,* W.J. Loesche/ and P.A. DeRouen*
The assessment of relationships between site-specific variables has been a matter of
controversy because of the claim that periodontal sites within individuals can be used as
independent observations in statistical models. One problem with this approach is the
unreliability of the calculated Type I and Type II error rates. Another problem is that
such inappropriate analysis may prohibit a correct assessment of causal relationships
between site-specific variables. The host-factor can act as an effect modifier and modulate
the magnitude of the site-specific effects and/or the host-factor can act as a confounder
by superimposing a patient-effect on the studied site-specific effects leading to bias. As
a result, site-specific biological mechanisms of disease progression may be misinter-
preted. Sites can be used as the experimental unit of analysis, but the sampling design
from which the site-specific data originated should not be ignored. / Periodontol
1990;61:368-372.
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Several investigators suggest that averaging site-specific in-
formation within patients obscures the clinical and micro-
biological reality of periodontal disease and accordingly
recommend that data analysis should occur on a site-spe-
cific basis.1"3 However, the practical realization of this ap-
proach has been complicated by the fact that inappropriate
statistical techniques were used.4-5 Sites within a patient
cannot be assumed independent as they are inherently cor-
related.6 For instance, periods of disease activity in a pa-
tient may be correlated due to a genetic and/or systemic
predisposition, or treatment responses may be correlated
due to the presence of an immunological response. It has
been reported that ignoring this dependence is likely to
increase the probability of a Type I error: a conclusion of
significant differences when there are no 'true' differences
present.7-8
Since causal inferences are often based on a probabilistic
framework, statistical models built on incorrect assump-
tions can also affect the causal assessment of the investi-
gated associations. If site-specific data are pooled, ignoring
the patient as a covariate, inconsistent biological phenom-
ena across patients can remain undetected, the strength of
an association can be over- or underestimated, and the spec-
ificity of an association can be obscured due to the pooling
of heterogeneous data. Although these three factors, strength,
consistency, and, specificity, are not necessary criteria to
justify inferring causal relationships, they have been rec-
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ommended as the most useful criteria for separating asso-
ciation from causation.9-10 If they are misrepresented and/
or ignored as a result of inappropriate analyses, the assess-
ment of causality may be endangered, since it cannot be
evaluated whether characteristics associated with the patient
factor acted as a confounding factor (defined as a distortion
of the effect measure), or as an effect modifier (defined as
different values of the effect measure at different levels of
patient characteristics).
The purpose of this paper is to show that the assessment
of the relationships between site-specific variables requires
adjustments for the patient as an additional source of var-
iation, not only for statistical reasons, but also for inferring
causal relationships. Common important criteria such as
strength, consistency, and specificity, and related concepts
such as effect-modification and confounding used for as-
sessing the causality of a relationship between site-specific
variables may become obscured with inappropriate anal-
yses. Some of the issues are illustrated with an example.
GENERAL PROCEDURE
The search for etiological agents in periodontal disease is
often focused on attempting to establish causal relationships
between site-specific variables. For instance, studies which
try to establish a relationship between a putative patholog-
ical organism (a site-specific factor) and disease activity (a
site-specific response) would fall under this category. Most
statistical methods appropriate for analyzing these types of
data address to a certain extent the following questions: 1)
are the observed site-specific associations consistent (ho-
mogeneous) across patients? 2) what is the strength of the
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association? and 3) is the association significant? These
different steps will be discussed in the following paragraphs.
Consistency
Commonly, the first step consists of investigating whether
the (site-specific) associations, estimated at the level of the
individual patient, are consistent across patients. The con-
cept of this testing for consistency (or homogeneity) of
multiple within-patient (e.g., site-specific) responses across
patients is relatively unique to dentistry. Medical investi-
gations, especially when related to the inference of caus-
ality, commonly investigate the consistency of patient-specific
responses across different groups of patients or populations.
However, the principles involved for both medical or dental
studies are similar. When patients are the elementary unit
of analysis, the consistency is evaluated across different
groups of patients or populations. When sites are the ele-
mentary unit of analyses, the consistency of the responses
should be evaluated across patients.
Two general approaches can be used to analyze the data
and to evaluate the consistency of the associations across
patients: stratified analyses and/or mathematical modeling
techniques. Stratified analyses offer the advantage of being
relatively simple to perform and easy to interpret. Also, a
limited number of assumptions are necessary to perform the
statistical analysis. Inferences of the results of stratified
analyses are usually restricted to only those patients of the
sample. Mathematical modeling offers the advantage of a
more parsimonious presentation of the data and the possi-
bility to make inferences to the population; however, math-
ematical models, such as random effects models, make
distributional assumptions about patient effects (e.g., that
patient effects are normally distributed with mean zero).
Care should be taken when these models are used to insure
that the assumptions hold approximately true for the data
at hand; violation of this assumption may lead to misleading
conclusions when the patient effects are heterogeneously
(inconsistently) distributed.
Stratified analyses may offer the opportunity to use for-
mal hypothesis tests to investigate the consistency (homo-
geneity) of the observed associations. However, it is generally
accepted that the determination of (in)consistency of asso-
ciations cannot be evaluated by merely testing the hypoth-
esis of homogeneity at some preset significance level.
Important factors such as the number of patients and the
number of sites sampled per patient need to be considered
when evaluating the P-value from a test of homogeneity.
Apart from statistical considerations, the choice of an ap-
propriate Type-I error rate needs to be determined by how
much heterogeneity the investigator is willing to accept. In
the clinical sciences it can be too much to expect constant
effects across all patients or groups of patients. What is one
person's homogeneity may be another person's heteroge-
neity, and vice-versa.11 In general, conclusions with regard
to homogeneity should be made with great care, and the
primary objective should not be to show that associations
are inconsistent across patients, but rather to evaluate to
what extent (and on what scale) associations may be con-
sidered homogeneous across patients.11
Dispite this subjectivity involved in investigating the (in)
consistent nature of the associations with data, the evalu-
ation process and the resulting conclusions can be impor-
tant; it can convey significant biological information to the
investigator, generate new hypothesis, suggest the presence
of additional causal mechanisms, and dictate the direction
of further statistical analysis.12-14 Obviously, the finding
that associations are consistent across patients provides one
supportive argument in favor of the studied causality of the
association and may permit the use of more sophisticated
mathematical models.
The finding that the associations are inconsistent results
in a more challenging problem. Sometimes obvious incon-
sistent responses can be separated and further analysis per-
formed on homogeneous subgroups. A thorough screening
of patient-specific covariates such as sex, immunological
criteria, the use of certain medications, etc. and their co-
incidence with the subgroups may be of significant value
in understanding and interpreting the results of the study.
A certain amount of subjective judgment may be required
to identify and describe the (homogeneous) subgroups and
any resulting findings should not be interpreted as conclu-
sions, but rather as an hypothesis-generating part of the
study. In other instances, the characterization of different
homogeneous subgroups and their possible relationships to
patient-specific characteristics may be impossible.
Strength of the Association
After this important first step of investigating the consis-
tency of the observed association across patients, the second
step is to investigate the strength of the association by es-
tablishing the direction and the magnitude of the relation-
ship. Depending on the study design and the categorical or
continuous nature of the data, several measures of associ-
ation are available for use: odd ratios, relative risk esti-
mates, average slope estimates, etc. When no confounding
patient effects are present, the results of analysis which
ignore the patient as a covariate (i.e., assume independence
of sites), and analyses which take into account the patient
(stratified analyses or mathematical modeling techniques)
will result in similar estimates of strength of association.
However, when confounding patient-effects are present,
differences in the magnitude as well as the direction of the
estimates may result between adjusted and unadjusted
analyses.
Significance of the Association
As a final step in the analysis, the relationship can be tested
at a preset significance level. This is also sometimes called
a test for main effects: it will test the significance of the
relationship between the site-specific variables. This aspect
of the analysis has been discussed in several reports.4-7
The circumstances under which these statistical topics
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become important for the biological interpretation of the
data are twofold: the patient factor can act as an effect
modifier and/or a confounding factor. An effect modifier
refers to a change of the effect of a site-specific exposure
variable according to a patient-specific characteristic. For
example, different levels of neutrophil status could possibly
act as an effect modifier upon the association between site-
specific bacterial pathogenicity and disease progression. A
confounding patient-effect refers to a super-imposition of
the effect of a patient-specific factor on the estimated re-
lationship between two site-specific variables. For example,
pregnancy could act as a confounding variable in studies
where the site-specific effect of a specific bacterial exposure
variable on the presence of bleeding is evaluated. (Preg-
nancy may be a risk factor for gingival bleeding due to
hormonal changes and its interaction with other bacterial
exposures and may, at the same time, be related to the
exposure variable under study.) These two biological con-
cepts, effect modification and confounding due to patient
effects, may be difficult to evaluate with analyses which
ignore the sampling design from which the site-specific data
originated. Stratified analyses as suggested above may often
provide some guidance in the evaluation of the patient-
effects (i.e., effect modification could present itself as sig-
nificant heterogeneity of the observed site-specific associ-
ations across patients, and confounding could be detected
due to large differences between the unadjusted and ad-
justed site-specific associations). In some instances, patient
effects could act as effect modifiers and confounding factors
simultaneously. A more detailed discussion of these issues
can be found in several reference works.10J4-16
AN EXAMPLE
As a numerical example, consider the following hypothet-
ical data from a case-control study: an investigator is in-
terested in assessing the hypothesis that site-specific exposure
to factor A causes a specific periodontal disease condition;
155 sites with a certain disease characteristic (cases) and
164 sites without the condition (controls) are selected from
8 patients and classified according to their exposure to fac-
tor A. The data are presented in Table 1.
Two fundamentally different approaches are possible for
this dataset: 1) one (inappropriate) approach would be to
assume that sites are independently distributed and that the
sampling design from which the data originated are irrele-
vant to the statistical model employed; and 2) another ap-
proach would be to stratify the data based on the patients,
or, to use a more sophisticated mathematical modeling ap-
proach where certain assumptions will need to be made
about the distribution of the patient effect (i.e., normally
distributed). For both approaches the hypothesis of interest
is that the presence of factor A is associated with the disease
characteristic.
As a first approach, it will be assumed that the sampling
design from which the site-specific data originated cannot
be ignored and that the patient factor needs to be adjusted
Table I. Hypothetical Data From a Case Control Study
Patient Sex D-/E" D+/E- D"/E+ D+/E+ Odds ratio
1 F 7 9 1 22 17.11
2 F 6 14 1 23 9.86
3 F 9 12 2 20 7.50
4 F 8 13 1 21 12.92
5 M 7 1 18 1 0.39
6 M 4 2 19 3 0.32
7 M 9 3 33 5 0.45
8 M 10 3 29 3 0.34
Total 60 57 104 98 0.99*
D+ and D~ represent respectively the presence or absence of the disease
factor of interest. E+ and E~ represent respectively the presence and ab-
sence of a suspected etiological cause, factor A. Site-specific analyses
which ignore the patient as a covariate would only use the total counts in
their analyses and yield the corresponding unadjusted odd's ratio(*)
for in the analysis. To keep the analyses simple, a stratified
analysis approach to the data will be employed.16 For every
patient in the study a four-fold table is constructed with site
as the experimental unit of analysis. Subsequently, in at-
tempting to combine information from all tables, three
questions are investigated:15 1) Is there evidence that the
site-specific degree of association between the factor and
the periodontal condition is consistent from patient to pa-
tient? 2) How large is the association as quantified by the
odds ratio? and 3) Is the degree of site-specific association
significant?
In a first step we can investigate the consistency of the
site-specific responses across patients by using the Breslow-
Day statistic.16 The lower the  value for this statistic, the
more likely it is the data are inconsistent (i.e., heteroge-
neous). Since for this example the  value of the Breslow-
Day statistic is < 0.001, the test for the homogeneity of
the effect is rejected and a careful reexamination of the data
is indicated. A visual examination of the odds ratios of
Table 1 reveals two different patient groups; one group in
which exposure to factor A seems to be positively associ-
ated with the periodontal disease characteristic (those pa-
tients with odds ratios > 1), suggesting that factor A may
cause the disease characteristic, and another group of pa-
tients where factor A seems to be negatively associated with
the disease characteristic (those patients with odds ratios <
1), suggesting that factor A may prevent the disease
characteristic.
A first approach to this heterogeneity could be to assume
that there is nothing peculiar about those inconsistencies
and that the data should be analyzed as presented. Since
the concept of homogeneity of effects is not a direct as-
sumption of the Mantel-Haenszel procedures, it offers a
valid analytic approach.17 The results of the analysis are
shown in Table 2. The direction and extent of the relation-
ship between factor A and the presence of the disease char-
acteristic is quantified with the Mantel-Haenszel summary
estimate of the odds ratio. The odds ratio of 2.4 suggests
that the odds of exposure to factor A among diseased sites
is 2.7 times larger than the odds of expose to factor A
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Table 2. Site-Specific Analysis Stratified on Patient
 ,:  2 = 26.87 DF = 7 Prob < 0.001
Summary Odds Ratio = 2.37 95% Confidence Bounds = {1.38,4.08}
H2:  2 = 9.74 DF = 1 Prob = 0.002
Estimation of the association between factor A and the disease character-
istic adjusted for the patient-effects. H, tests the homogeneity of the re-
sponses across patients. For this example the test is highly significant
indicating significant heterogeneity. H, tests the significance of the overall
association regardless of any heterogeneity, demonstrating a highly sig-
nificant association between factor A and the disease characteristic.
Table 3. Site-Specific Analysis Stratified on Patient: Separation of
Groups With Opposing Odds Ratios
Table 4. Site-specific Analysis Without Adjustment for the Patient
Effects
 :  2 = 0.001
Crude Odds Ratio = 0.99
DF = 1 Prob = 0.972
95% Confidence Bounds = {0.63,1.56}
 ,:  2 = 0.377
Summary Odds Ratio
H2:  2 = 27.13
 ,:  2 = 0.09
Summary Odds Ratio
 ,:  2 = 3.92
Males
DF = 3 Prob = 0.945
10.77 95% Confidence Bounds = {4.40,26.34}
DF = 1 Prob = 0.001
Females
DF = 3 Prob = 0.993
0.38 95% Confidence Bounds = {0.15,0.99}
DF = 1 Prob = 0.048
  is the test for homogeneity and H2 is the test of significance for the
overall association. Results of Table 2 are presented separately for males
and females.
among non-diseased sites. The significance of this associ-
ation is investigated with the Mantel-Haenszel  2 statistic,
which indicates a significant association between the pres-
ence of factor A and the disease characteristic at an alpha
level of 0.05 (P = 0.002).18 The conclusion of this site-
specific analysis, which adjusted for patient effects by treat-
ing each as a stratum, indicated a significant association
between the presence of factor A and the presence of the
disease characteristic at periodontal sites. Although this ap-
proach is statistically correct, the results of such analyses
may be considered improper and potentially misleading,
since the patient-specific associations vary enough to in-
dicate that there may be some other underlying effect mod-
ifier present.
A better approach would be to assume that there may be
some biological explanation for the significant heteroge-
neity and to screen for patient-specific factors which may
explain the inconsistency of the associations. Assuming for
the sake of the example that the opposing trends of odds
ratios coincided with sex, one simple approach would be
to present the estimates separately for males and females.
The strength, consistency, and significance of the associ-
ation could be reassessed for the two subgroups as shown
in Table 3. Within both sexes there is homogeneity of pa-
tient-effects (P > 0.95) and there exists significant, but
opposing, associations between the factor and the disease
characteristic. These findings could form a basis for future
studies where the effect modification of sex on factor A
could further be evaluated.
The previous analyses can be contrasted with the site-
specific analysis where the patient as a source of variation
is ignored (Table 4). The odds of exposure to factor A are
approximately equal for diseased and non-diseased sites.
Analysis using pooled data. Note the switch-over bias and the absence of
a significant association.  represents the hypothesis for testing signifi-
cance of the crude (or unadjusted) association.
This association is of course insignificant (P = 0.99). The
conclusion of this site-specific analysis, which does not
adjust for the patient as a covariate, suggests that there is
no association between the presence of a factor A and the
disease characteristic.
Two issues for the analyses of site-specific data are il-
lustrated in this example. First, adjustment for the patient
may apparently yield different associations from unadjusted
analyses (i.e., assuming that sites are independent). The
switch-over bias seen in this example (from an odds ratio
of 0.99 for the unadjusted analysis to an odds ratio of 2.4
for the adjusted analysis) is partly due to the fact that the
patient-effect acted as a confounding factor. Apart from the
site-specific factor under investigation, a patient-specific
factor was responsible for an effect. There seemed to be a
trend for high prevalence of the exposure and a low risk
for disease in the male group, and a low prevalence of
exposure but a high risk for the disease in the female group.
Hence, ignoring the confounding variable sex will make
the association between the disease and the exposure appear
less positive than it should be. (This assessment however
may be irrelevant due to the highly significant interaction).
Second, investigation of the homogeneity of the site-spe-
cific responses at a patient-level may play an important role
for subsequent statistical analyses and for the interpretation
of the data. Effect-modification of the patient-specific char-
acteristics on the site-specific exposure variables can sig-
nificantly affect the interpretation of the data and further
analysis.
DISCUSSION
In many health research investigations, the relationship be-
tween a primary factor (e.g., a putative bacteriological or-
ganism) and the response variable (e.g., disease activity) is
influenced by additional variables (e.g., the "patient" fac-
tor) which are also associated with the response variable.19
These additional variables can be labeled as intervening
variables, confounding variables, effect modifiers, or cov-
ariables. Appropriate adjustments for these variables are
necessary for a correct assessment of the relationship be-
tween site-specific variables. A wide variety of statistical
models are available for the analysis of site-specific
data.20-25 And, although the choice of the most suitable
statistical technique may not always be straightforward, ex-
treme solutions such as assuming that periodontal sites are
independent units of observation should be avoided.
Adjustment for the patient as a covariate may have im-
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portant implications for the assessment of relationships be-
tween site-specific variables. Inconsistencies in the
associations across patients can suggest the presence of ad-
ditional causal mechanisms which may not have been con-
sidered in the study design.12 Consequently, it could form
a contra-indication for pooling the site-specific data across
patients and stimulate further inquiry on the host factor of
those patients who responded differently. Occasionally, in-
consistencies of the associations at a population level have
generated new hypotheses that led to a better understanding
of dental disease processes. For instance, inconsistent re-
lationships between the plaque indices and both dental de-
cay and periodontal disease severity provided an argument
to support the specific-plaque hypothesis.26-27
Similarly, inconsistent responses at a patient level may
be important in the study of periodontal disease. Several
clinical trials, for instance, have indicated that for a given
set of patients with an apparently similar periodontal disease
history, disease activity seems to occur in a small subset
of the studied subjects.28 Such findings would indicate that
certain patient-factors may act as an effect modifier. If for
analytic purposes the sites of all studied subjects are pooled
without due consideration to the host-factor, associations
between etiologic factors and disease activity, present in
the small subgroup of patients, may be misrepresented. Site-
specific analyses which adjust for patient-effects may dis-
close characteristics of site-specific infections in periodon-
tal disease entities which are clinically not self-evident, but
which may become apparent through the investigation of
the homogeneity of associations across patients. In general,
analyses which take into account the sampling design from
which the site-specific data originate may uncover unex-
pected departures from original hypothesis and isolate in-
teresting patterns or features of the data.
Site-specific bacterial factors are most likely necessary,
but not sufficient, causes of periodontal disease progres-
sion. Other components of sufficient causes are undoubt-
edly related to host factor characteristics such as the immune
system. Consequently, the selection of an appropriate analysis
for the site-specific data of a study is more than just a
"statistical issue." Important concepts of causality such as
consistency, strength, and specificity of an association may
become obscured as a result of inappropriate analysis, and,
more importantly, related topics such as effect modification
due to the patient characteristics and/or confounding patient
effects may become difficult to assess. It is concluded that
sites can be used as the experimental unit of analysis, but
that the sampling design from which the site-specific data
originated should not be ignored.
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